Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Management appointments at Peplin

This article was originally published in Scrip

Executive Summary

Peplinhas named Tom Wiggans chief executive officer. He is currently chairman of Peplin's board of directors and will also continue in that role. Before joining the company, Mr Wiggans served as chairman of the board and CEO of Connetics; he left this role in December 2006 when Connetics was acquired by Stiefel Laboratories. In addition, Peplin has appointed Dr Eugene Bauer president and chief medical officer. Dr Bauer was most recently CEO of Neosil, which has entered into a merger agreement with Peplin.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel